Relay Therapeutics
Relay Therapeutics58
About
What does Relay Therapeutics do?
Relay Therapeutics is a clinical-stage precision medicine company that integrates computational and experimental technologies to understand protein motion and transform drug discovery. Their proprietary Dynamo Platform visualizes how proteins move, enabling precise drug design for targets previously considered intractable. The company is advancing a pipeline of medicine candidates for precision oncology and genetic diseases.
What is Relay Therapeutics's revenue?
StartupHub estimates Relay Therapeutics's annual revenue at $61.3M (range $35.7M to $357.3M, 28% confidence), based on comparable companies in the sector.
What is Relay Therapeutics's valuation?
StartupHub estimates Relay Therapeutics's effective valuation at $3.2B (range $2.1B to $5.0B, 21% confidence), based on comparable companies in the sector.
How much funding has Relay Therapeutics raised?
Relay Therapeutics has raised a total of $825M in funding. The most recent round on record is Public Offering.
Where is Relay Therapeutics headquartered?
Relay Therapeutics is headquartered in Cambridge, United States.
When was Relay Therapeutics founded?
Relay Therapeutics was founded in 2015.
What industry does Relay Therapeutics operate in?
Relay Therapeutics operates in Biotech, Drug Discovery, Precision Medicine, Oncology, Genetic Disease, Computational Biology.
No comments yet. Be the first to share your take.